Status:
UNKNOWN
Human Papillomavirus and Pregnancy
Lead Sponsor:
Ulla Bonde van Zwol
Collaborating Sponsors:
MCM Vaccines B.V.
Region of Southern Denmark
Conditions:
HPV-infection in Pregnant Women
Eligibility:
FEMALE
15-60 years
Brief Summary
Purpose Our study involves two hypotheses. One is that genital infection with HPV is associated with increased risk of miscarriage and preterm birth. The second hypothesis is that human papillomavirus...
Detailed Description
Background Studies have shown significantly higher prevalence of HPV in tissue from miscarriages (60%) than from induced abortions (20%). HPV-infection in the extravillous trophoblasts in the placenta...
Eligibility Criteria
Inclusion
- Pregnant women gestational week 10-42
Exclusion
- Vaccinated against cervical cancer
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
546 Patients enrolled
Trial Details
Trial ID
NCT01897129
Start Date
November 1 2011
End Date
November 1 2015
Last Update
July 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gynecology and Obstetrics
Odense, Funen, Denmark, 5000